LINCOCIN

Clindamycin Hydrochloride BP

ANTIEFECTIVE » LINCOSAMIDE

INDICATION

Clindamycin has been shown to be effective in the treatment of the following infections when caused by susceptible anaerobic bacteria or susceptible strains of gram positive bacteria such as Streptococci, Staphylococci and Pneumococci; Upper respiratory infections, Lower respiratory infections, Skin and soft tissue infections, Bone and joint infections, Pelvic infections, Intra-abdominal infections, Septicemia and endocarditis, Dental infections. As alternative therapy when used in combination with quinine or amlodiaquine for the treatment of multi-drug resistant Plasmodium infection. 

DOSAGE AND ADMINISTRATION

Severe anaerobic infections: 

Adult: 150-300 mg 6 hourly, up to 450 mg in severe infections. Max: 1.8 g/day.

Child: 3-6 mg/kg 6 hourly.

Or AS DIRECTED BY THE PHYSICIAN.

COMPOSITION

Each capsule contains Clindamycin Hydrochloride BP equivalent to Clindamycin 150 mg.

Each capsule contains Clindamycin Hydrochloride BP equivalent to Clindamycin 300 mg.